Clinical Trial Update: A Placebo-Controlled Single-Dose Trial of Sildenafil in Schizophrenia [Phase 4]

View source ↗

Summary

A Phase 4, placebo-controlled single-dose trial of sildenafil in schizophrenia conducted by Massachusetts General Hospital has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• SILDENAFIL (SILDENAFIL)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED